If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksResolute Mining Regulatory News (RSG)

Share Price Information for Resolute Mining (RSG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.60
Bid: 24.00
Ask: 24.60
Change: 1.60 (7.05%)
Spread: 0.60 (2.50%)
Open: 23.40
High: 24.80
Low: 23.40
Prev. Close: 22.70
RSG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proposed issue of securities - RSG

10 Nov 2022 07:00

RNS Number : 9257F
Resolute Mining Limited
10 November 2022
 

Proposed issue of securities

 

Announcement Summary

 

Entity name

RESOLUTE MINING LIMITED

 

Announcement Type

New announcement

 

Date of this announcement

10/11/2022

 

The Proposed issue is:

A placement or other type of issue

 

Total number of +securities proposed to be issued for a placement or other type of issue

 

ASX +security code

RSG

 

+Security description

ORDINARY FULLY PAID

 

Maximum Number of

+securities to be issued

258,000,000

 

Proposed +issue date

18/11/2022

 

 

Refer to next page for full details of the announcement

 

 

 

 

1.1 Name of +Entity

RESOLUTE MINING LIMITED

We (the entity named above) give ASX the following information about a proposed issue of +securities and, if ASX agrees to +quote any of the +securities (including any rights) on a +deferred settlement basis, we agree to the matters set out in Appendix 3B of the ASX Listing Rules.

 

If the +securities are being offered under a +disclosure document or +PDS and are intended to be quoted on ASX, we also apply for quotation of all of the +securities that may be issued under the +disclosure document or +PDS on the terms set out in Appendix 2A of the ASX Listing Rules (on the understanding that once the final number of +securities issued under the +disclosure document or +PDS is known, in accordance with Listing Rule 3.10.3C, we will complete and lodge with ASX an Appendix 2A online form notifying ASX of their issue and applying for their quotation).

 

1.2 Registered Number Type

CAN

 

Registration Number

097088689

 

1.3 ASX issuer code

RSG

 

1.4 The announcement is

New announcement

 

1.5 Date of this announcement

10/11/2022

 

1.6 The Proposed issue is:

A placement or other type of issue

 

 

 

 

 

 

Part 7 - Details of proposed placement or other issue

 

 

Part 7A - Conditions

 

7A.1 Do any external approvals need to be obtained or other conditions satisfied before the placement or other type of issue can proceed on an unconditional basis?

No

 

Part 7B - Issue details

Is the proposed security a 'New

class' (+securities in a class that is

not yet quoted or recorded by ASX)

or an 'Existing class' (additional

securities in a class that is already

quoted or recorded by ASX)?

Existing Class

 

Will the proposed issue of this

+security include an offer of

attaching +securities?

No

 

 

Details of +securities proposed to be issued

 

ASX +security code and description

RSG : ORDINARY FULLY PAID

 

Number of +securities proposed to be issued

258,000,000

 

Offer price details

 

Are the +securities proposed to be issued being issued for a cash

consideration?

Yes

 

In what currency is the cash

consideration being paid?

AUD - Australian Dollar

 

What is the issue price per

+security?

AUD 0.16000

 

Will these +securities rank equally in all respects from their issue date with

the existing issued +securities in that class?

Yes

 

 

 

 

Part 7C - Timetable

 

 

7C.1 Proposed +issue date

18/11/2022

 

Part 7D - Listing Rule requirements

 

7D.1 Has the entity obtained, or is it obtaining, +security holder approval for the entire issue under listing rule 7.1?

No

 

7D.1b Are any of the +securities proposed to be issued without +security holder approval using the entity's 15% placement capacity under listing rule 7.1?

Yes

 

7D.1b ( i ) How many +securities are proposed to be issued without security holder approval using the entity's 15% placement capacity under listing rule 7.1?

258000000

 

7D.1c Are any of the +securities proposed to be issued without +security holder approval using the entity's additional 10% placement capacity under listing rule 7.1A (if applicable)?

No

 

7D.2 Is a party referred to in listing rule 10.11 participating in the proposed issue?

No

 

7D.3 Will any of the +securities to be issued be +restricted securities for the purposes of the listing rules?

No

 

7D.4 Will any of the +securities to be issued be subject to +voluntary escrow?

No

 

 

Part 7E - Fees and expenses

 

 

7E.1 Will there be a lead manager or broker to the proposed issue?

Yes

 

7E.1a Who is the lead manager/broker?

Canaccord Genuity (Australia) Limited (ACN 075 071 466) and Sprott Capital Partners LP (Joint Lead Managers) in their agreed respective proportions (being Canaccord Genuity (Australia) Limited as to 50% and Sprott Capital Partners LP as to 50% (Respective Proportions).

 

Euroz Hartleys Limited (Euroz) and Joh. Berenberg, Gossler & Co. KG, London Branch (Berenberg) are co-managers (Co- Managers).

 

 

 

 

 

 

 

7E.1b What fee, commission or other consideration is payable to them for acting as lead manager/broker?

The Joint Lead Managers will receive a management and arranging fee equal to 1% (excluding GST) of the aggregate proceeds of the Placement in their Respective Proportions (Placement Management Fee).

 

Resolute may, in its sole and absolute discretion, pay the Joint Lead Managers an incentive fee of up to 0.5% of the proceeds of the Placement in their Respective Proportions,

 

The Joint Lead Managers are responsible for paying the fees of the Co-Managers.

 

7E.2 Is the proposed issue to be underwritten?

Yes

 

7E.2a Who are the underwriter(s)?

Canaccord Genuity (Australia) Limited (ACN 075 071 466) and Sprott Capital Partners LP

 

7E.2b What is the extent of the underwriting (ie the amount or proportion of the proposed issue that is

underwritten)?

Fully underwritten

 

7E.2c What fee, commission or other consideration is payable to them for acting as underwriter(s)?

The Joint Lead Managers will receive an underwriting fee equal to 3% (excluding GST) of the proceeds from Placement in their Respective Proportions.

 

7E.2d Please provide a summary of the significant events that could lead to the underwriting being terminated.

Please see ¿Summary of the Underwriting Agreement¿ in Resolute¿s Investor Presentation dated 10 November 2022.

 

This includes a summary of the significant events that could lead to the Underwriting Agreement being terminated.

 

7E.3 Is a party referred to in listing rule 10.11 underwriting or sub-underwriting the proposed issue?

No

 

7E.4 Details of any other material fees or costs to be incurred by the entity in connection with the proposed issue

Treadstone Resource Partners, Resolute¿s independent corporate advisor, will receive an advisory fee equal to 0.5% of the proceeds raised under the Placement and Entitlement Offer. The advisory fee will be capped at US$350,000.

 

Resolute may, in its sole and absolute discretion, pay Treadstone Resource Partners an incentive fee of up to US$50,000.

 

Standard share registry, legal and other external adviser fees and ASX administrative fees.

 

 

 

Part 7F - Further Information

 

 

7F.01 The purpose(s) for which the entity is issuing the securities

For additional working capital and to fund the retirement of debt - please refer to the Investor Presentation as announced to ASX on 10 November 2022 for further details.

 

7F.1 Will the entity be changing its dividend/distribution policy if the proposed issue proceeds?

No

 

 

 

 

7F.2 Any other information the entity wishes to provide about the proposed issue

The institutional placement will only be extended to Aus,NZ,Bermuda,Canada (BC, Ont and Quebec only),Cayman Islands,EU,HK,Liechtenstein,Mauritius,Monaco,Norway,SG,Switzerland,UK + ltd private placement to US eligible institutional shareholders.

 

7F.3 Any on-sale of the +securities proposed to be issued within 12 months of their date of issue will comply with the secondary sale provisions in sections 707(3) and 1012C(6) of the Corporations Act by virtue of:

The publication of a cleansing notice under section 708A(5), 708AA(2)(f), 1012DA(5) or 1012DAA(2)(f)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFFISDSEESEFF
Date   Source Headline
27th Jan 20237:00 amRNSQuarterly Conference Call Details
19th Jan 20237:00 amRNSOver Three M Ounce Mineral Resource at Syama North
12th Jan 20237:00 amRNSResolute achieves ISO 14001 45001 certification
28th Dec 20229:20 amRNSNotification of cessation of securities - RSG
28th Dec 20229:15 amRNSApplication for quotation of securities - RSG
19th Dec 20229:03 amRNSAppendix 3Y Martin Botha
19th Dec 20228:33 amRNSAppendix 3Y Mark Potts
9th Dec 20227:00 amRNSApplication for quotation of securities - RSG
7th Dec 202211:52 amRNSPublication of LSE Prospectus
7th Dec 20227:00 amRNSSuccessful completion of retail entitlement offer
30th Nov 202211:13 amRNSMines and Money Presentation
28th Nov 20227:00 amRNSOperational Update - Bibiani Sale Consideration
18th Nov 20227:00 amRNSSection 708(5)(e) Cleansing Notice
17th Nov 20227:00 amRNSApplication for quotation of securities - RSG
17th Nov 20227:00 amRNSApplication for quotation of securities - RSG
17th Nov 20227:00 amRNSNominee Letter
17th Nov 20227:00 amRNSIneligible Shareholders Letter
17th Nov 20227:00 amRNSEligible Shareholders Letter
17th Nov 20227:00 amRNSRetail Offer Booklet
17th Nov 20227:00 amRNSRetail Entitlement Offer Open For Acceptance
14th Nov 20227:00 amRNSUpdate - Proposed issue of securities - RSG
14th Nov 20227:00 amRNSInstitutional Offer Done Underwriting up to A$164m
14th Nov 20227:00 amRNSUpdate - Proposed issue of securities - RSG
10th Nov 20227:00 amRNSProposed issue of securities - RSG
10th Nov 20227:00 amRNSProposed issue of securities - RSG
10th Nov 20227:00 amRNSNotice under section 708AA(2)(f) of Corps Act 2001
10th Nov 20227:00 amRNSInvestor Presentation
10th Nov 20227:00 amRNSA$140m underwritten Raise to enhance balance sheet
27th Oct 20227:00 amRNSSeptember 2022 Quarterly Activities Report
26th Oct 20227:00 amRNSQuarterly Conference Call Details
20th Oct 20227:00 amRNSSecond instalment of final Bibiani tranche paid
17th Oct 20227:00 amRNSResponse to media article
20th Sep 20227:00 amRNSFirst Instalment of Final Bibiani Tranche Paid
19th Sep 20227:00 amRNSDenver Gold Forum Presentation
1st Sep 20227:08 amRNSTwo Million Ounce Mineral Resource at Syama North
31st Aug 20227:00 amRNSPresentation at Africa Down Under Conference
30th Aug 20227:00 amRNSTwo Million Ounce Mineral Resource at Syama North
25th Aug 20227:00 amRNS2022 Half Year Financial Results Summary
25th Aug 20227:00 amRNS2022 Half Year Financial Results Presentation
25th Aug 20227:00 amRNS2022 Half Year Financial Results and Accounts
23rd Aug 20227:00 amRNSHalf Year Results Calls
28th Jul 20227:00 amRNSJune 2022 Quarterly Activities Report
25th Jul 20229:33 amRNSQuarterly Conference Call Details
5th Jul 20227:00 amRNSResolute Operational Update- Mali sanctions lifted
28th Jun 20227:25 amRNSAppendix 3G
28th Jun 20227:19 amRNSAppendix 2A
28th Jun 20227:00 amRNSAppendix 3Y Terence Holohan
16th Jun 20227:00 amRNSHigher Grade mineralisation intersected
23rd May 20227:00 amRNSAppendix 3X
23rd May 20227:00 amRNSTerry Holohan formally appointed as CEO & MD

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.